Argentina Biopharmaceutical Market Size & Outlook, 2026-2033
The biopharmaceutical market in Argentina is expected to reach a projected revenue of US$ 2,834.5 million by 2033. A compound annual growth rate of 6.3% is expected of Argentina biopharmaceutical market from 2026 to 2033.
F. Hoffmann-La Roche Ltd., Novartis AG ADR, AbbVie Inc., Johnson & Johnson Services, Inc., Merck & Co., Inc., Pfizer Inc., Bristol-Myers Squibb Company, Sanofi SA, GSK PLC ADR, AstraZeneca PLC, Takeda Pharmaceutical Company Limited, Biogen Inc, Eli Lilly and Company, Novo Nordisk A/S ADR, Amgen Inc.
Other key industry trends
In terms of revenue, Argentina accounted for 0.4% of the global biopharmaceutical market in 2025.
Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
In Latin America, Brazil biopharmaceutical market is projected to lead the regional market in terms of revenue in 2033.
Brazil is the fastest growing regional market in Latin America and is projected to reach USD 10,107.8 million by 2033.
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Biopharmaceutical Market Outlook will help companies and investors design strategic landscapes.
Monoclonal Antibody was the largest segment with a revenue share of 68.86% in 2025.
Horizon Databook has segmented the Argentina biopharmaceutical market based on monoclonal antibody, interferon, insulin, growth and coagulation factor, erythropoietin, vaccine, hormone covering the revenue growth of each sub-segment from 2021 to 2033.
Argentina Biopharmaceutical Market Molecule Type Outlook (Revenue, USD Million , 2021-2033)
Monoclonal Antibody
Interferon
Insulin
Growth and Coagulation Factor
Erythropoietin
Vaccine
Hormone
Others
Argentina Biopharmaceutical Market Disease Outlook (Revenue, USD Million , 2021-2033)
Oncology
Blood Disorder
Metabolic Disease
Infectious Disease
Cardiovascular Disease
Neurological Disease
Immunology
Other Applications
Argentina Biopharmaceutical Market Drug Type Outlook (Revenue, USD Million , 2021-2033)
Proprietary (Branded)
Biosimilars
Argentina Biopharmaceutical Market Drug Development Outlook (Revenue, USD Million , 2021-2033)
Outsource
In-house
Argentina Biopharmaceutical Market Formulation Outlook (Revenue, USD Million , 2021-2033)
Injectables (IV, IM, SC)
Inhalation/Nasal Sprays
Other Formulations
Argentina Biopharmaceutical Market Route of Administration Outlook (Revenue, USD Million , 2021-2033)
Parenteral (IV, IM, SC)
Inhalation/Nasal
Other Routes
Argentina Biopharmaceutical Market Prescription Type Outlook (Revenue, USD Million , 2021-2033)
Prescription Medicines
Over-the-counter (OTC) Medicines
Argentina Biopharmaceutical Market Sales Channel Outlook (Revenue, USD Million , 2021-2033)
Retail Pharmacies
Non-retail
Reasons to subscribe to Biopharmaceutical Market Outlook databook
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Biopharmaceutical Market Outlook databook
Our clientele includes a mix of Biopharmaceutical Market Outlook companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Argentina Biopharmaceutical Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into Argentina Biopharmaceutical Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Argentina Biopharmaceutical Market, 2021-2033 (US$M)